Bloomberg Daybreak: Asia Edition cover image

Trump Says He'll Set Unilateral Tariffs; China's Biotech Boom

Bloomberg Daybreak: Asia Edition

00:00

Surge in Biotech Investments and Regulatory Insights in China

This chapter analyzes the impressive 60% rise of the Hanson Biotech Index, driven by major investments from pharmaceutical giants like Pfizer in smaller biotech firms. It also examines the regulatory environment in China, highlighting its favorable stance towards Western drugs, which could benefit local companies entering the market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app